Peter R. Strack

3.6k total citations · 2 hit papers
34 papers, 2.8k citations indexed

About

Peter R. Strack is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Peter R. Strack has authored 34 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Peter R. Strack's work include Developmental Biology and Gene Regulation (7 papers), Cancer-related Molecular Pathways (6 papers) and Advanced Breast Cancer Therapies (4 papers). Peter R. Strack is often cited by papers focused on Developmental Biology and Gene Regulation (7 papers), Cancer-related Molecular Pathways (6 papers) and Advanced Breast Cancer Therapies (4 papers). Peter R. Strack collaborates with scholars based in United States, Italy and United Kingdom. Peter R. Strack's co-authors include Peggy Beer‐Romero, Stephen J. Elledge, Chia‐Yu Chu, J. Wade Harper, Jeffrey Winston, Giulio Draetta, A. Thomas Look, Jennifer O’Neil, Christopher Winter and Lucio Miele and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Genes & Development.

In The Last Decade

Peter R. Strack

34 papers receiving 2.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitro

1999 801 citations Jeffrey Winston, Peter R. Strack et al. Genes & Development profile →
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors

2007 523 citations Jennifer O’Neil, Jonathan Grim et al. The Journal of Experimental Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Peter R. Strack	2.1k	808	518	334	259	34	2.8k
Prathapan Thiru	2.3k 1.1×	1.0k 1.3×	1.1k 2.1×	315 0.9×	139 0.5×	22	3.7k
Mark A. Subler	2.0k 1.0×	1.5k 1.8×	412 0.8×	256 0.8×	63 0.2×	65	3.0k
Ruth W. Craig	2.3k 1.1×	965 1.2×	452 0.9×	734 2.2×	133 0.5×	44	3.3k
Irene M. Pedersen	2.5k 1.2×	529 0.7×	1.1k 2.1×	1.0k 3.0×	151 0.6×	27	3.6k
Barbara Majello	2.7k 1.3×	557 0.7×	408 0.8×	403 1.2×	57 0.2×	77	3.3k
Anthony G. Uren	2.5k 1.2×	598 0.7×	445 0.9×	514 1.5×	122 0.5×	32	3.1k
Jörn Krätzschmar	1.2k 0.6×	480 0.6×	313 0.6×	277 0.8×	217 0.8×	35	2.4k
Olle Sangfelt	2.3k 1.1×	1.3k 1.6×	553 1.1×	691 2.1×	119 0.5×	51	3.4k
Filippo Rosselli	2.5k 1.2×	712 0.9×	758 1.5×	216 0.6×	118 0.5×	76	2.9k
B Hoffman	1.9k 0.9×	1.1k 1.3×	435 0.8×	366 1.1×	68 0.3×	32	2.8k

Countries citing papers authored by Peter R. Strack

Since Specialization

Citations

This map shows the geographic impact of Peter R. Strack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Strack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Strack more than expected).

Fields of papers citing papers by Peter R. Strack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Strack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Strack. The network helps show where Peter R. Strack may publish in the future.

Co-authorship network of co-authors of Peter R. Strack

This figure shows the co-authorship network connecting the top 25 collaborators of Peter R. Strack. A scholar is included among the top collaborators of Peter R. Strack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter R. Strack. Peter R. Strack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Chaoxin, Venugopal Chenna, Shinichi Yabuuchi, et al.. (2015). Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models. Molecular Cancer Therapeutics. 14(7). 1532–1539. 60 indexed citations

Hicks, Alexandra, Huseyin Mehmet, Melody K. Morris, et al.. (2015). Pharmacological Inhibition of O-GlcNAcase Does Not Increase Sensitivity of Glucocorticoid Receptor-Mediated Transrepression. PLoS ONE. 10(12). e0145151–e0145151. 5 indexed citations

Yun, Jieun, Antonio Pannuti, Ignacio Espinoza, et al.. (2013). Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells. Oncogenesis. 2(8). e60–e60. 56 indexed citations

Yuan, Jing, Peter R. Strack, Carlo Toniatti, & Marc R. Pelletier. (2012). A zinc finger nuclease assay to rapidly quantitate homologous recombination proficiency in human cell lines. Analytical Biochemistry. 434(1). 96–98. 3 indexed citations

Lo, Shelly S., Kathy S. Albain, Patricia A. Robinson, et al.. (2010). Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.. PubMed. 30(10). 3853–67. 119 indexed citations

Efferson, Clay L., Christopher T. Winkelmann, Christopher Ware, et al.. (2010). Downregulation of Notch Pathway by a γ-Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model. Cancer Research. 70(6). 2476–2484. 76 indexed citations

Chen, Y-H., Santosh Kesari, Cliona M. Rooney, et al.. (2010). Inhibition of Notch Signaling Blocks Growth of Glioblastoma Cell Lines and Tumor Neurospheres. Genes & Cancer. 1(8). 822–835. 83 indexed citations

Rao, Sudhir, Jennifer O’Neil, James S. Hardwick, et al.. (2009). Inhibition of NOTCH Signaling by Gamma Secretase Inhibitor Engages the RB Pathway and Elicits Cell Cycle Exit in T-Cell Acute Lymphoblastic Leukemia Cells. Cancer Research. 69(7). 3060–3068. 114 indexed citations

Graziani, Irene, Melissa A. De Marco, Yuanbin Chen, et al.. (2008). Opposite Effects of Notch-1 and Notch-2 on Mesothelioma Cell Survival under Hypoxia Are Exerted through the Akt Pathway. Cancer Research. 68(23). 9678–9685. 94 indexed citations

10.

Chen, Yuanbin, Melissa A. De Marco, Irene Graziani, et al.. (2007). Oxygen Concentration Determines the Biological Effects of NOTCH-1 Signaling in Adenocarcinoma of the Lung. Cancer Research. 67(17). 7954–7959. 123 indexed citations

11.

Ginanni, Nicole, Yanai Zhan, Michael R. Tota, et al.. (2007). Kinetic analysis of the fatty acid synthesis pathway in HCT-116 colon cancer cells: role of FAS and ACC1 in maintaining tumor cell viability and proliferation. Cancer Research. 67. 4473–4473. 2 indexed citations

12.

O’Neil, Jennifer, Jonathan Grim, Peter R. Strack, et al.. (2007). FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors. The Journal of Experimental Medicine. 204(8). 1813–1824. 523 indexed citations breakdown →

13.

Lewis, Huw D., Peter R. Strack, Jennifer O’Neil, et al.. (2007). Apoptosis in T Cell Acute Lymphoblastic Leukemia Cells after Cell Cycle Arrest Induced by Pharmacological Inhibition of Notch Signaling. Chemistry & Biology. 14(2). 209–219. 110 indexed citations

14.

Rivkin, Alexey, Mark T. Goulet, Nathan Bays, et al.. (2006). 3-Aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(17). 4620–4623. 42 indexed citations

15.

Strack, Peter R., Maureen Caligiuri, Marc R. Pelletier, et al.. (2000). SCFβ-TRCP and phosphorylation dependent ubiquitination of IκBα catalyzed by Ubc3 and Ubc4. Oncogene. 19(31). 3529–3536. 33 indexed citations

16.

Winston, Jeffrey, Peter R. Strack, Peggy Beer‐Romero, et al.. (1999). The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitro. Genes & Development. 13(3). 270–283. 801 indexed citations breakdown →

17.

Korant, Bruce D., et al.. (1998). A Cellular Anti-Apoptosis Protein is Cleaved by the HIV-1 Protease. Advances in experimental medicine and biology. 436. 27–29. 18 indexed citations

18.

Strack, Peter R., Lloyd Waxman, & Julie M. Fagan. (1996). ATP-Stimulated Degradation of Oxidatively Modified Superoxide Dismutase by Cathepsin D in Cardiac Tissue Extracts. Biochemical and Biophysical Research Communications. 219(2). 348–353. 8 indexed citations

19.

Korant, Bruce D., et al.. (1996). HIV Protease Mutations Leading to Reduced Inhibitor Susceptibility. Advances in experimental medicine and biology. 389. 241–245. 2 indexed citations

20.

Strack, Peter R., et al.. (1992). Comparison of the multicatalytic proteinases isolated from the nucleus and cytoplasm of chicken red blood cells. International Journal of Biochemistry. 24(6). 887–895. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact